Predictors of the pathogenicity of methicillin‐resistant Staphylococcus aureus nosocomial pneumonia

The clinical characteristics of patients with nosocomial pneumonia (NP) associated with methicillin‐resistant Staphylococcus aureus (MRSA) infection are not well characterized.

[1]  R. Weinstein,et al.  Predictors of clinical virulence in community-onset methicillin-resistant Staphylococcus aureus infections: the importance of USA300 and pneumonia. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  T. Wiemken,et al.  Severity of disease and clinical outcomes in patients with hospital-acquired pneumonia due to methicillin-resistant Staphylococcus aureus strains not influenced by the presence of the Panton-Valentine leukocidin gene. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  M. Niederman.  The argument against using quantitative cultures in clinical trials and for the management of ventilator-associated pneumonia. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  D. Kuritzkes,et al.  Instantaneous inhibitory potential is similar to inhibitory quotient at predicting HIV-1 response to antiretroviral therapy. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  Yasuaki Yamada,et al.  Genetic diagnosis of community-acquired MRSA: a multiplex real-time PCR method for Staphylococcal cassette chromosome mec typing and detecting toxin genes. , 2010, The Tohoku journal of experimental medicine.

[6]  Mauricio Valencia,et al.  Ventilator-associated pneumonia , 2009, Current opinion in critical care.

[7]  M. Kollef,et al.  Pneumonia caused by methicillin-resistant Staphylococcus aureus. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  M. Kollef,et al.  The modified APACHE II score outperforms Curb65 pneumonia severity score as a predictor of 30-day mortality in patients with methicillin-resistant Staphylococcus aureus pneumonia. , 2008, Chest.

[9]  N. Shime,et al.  Current problems in the diagnosis and treatment of hospital-acquired methicillin-resistant Staphylococcus aureus pneumonia , 2008, Journal of Anesthesia.

[10]  M. Furue,et al.  Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan. , 2007, The Journal of antimicrobial chemotherapy.

[11]  C. Bridges,et al.  Severe Community-acquired Pneumonia Due to Staphylococcus aureus, 2003–04 Influenza Season , 2006, Emerging infectious diseases.

[12]  Marin H Kollef,et al.  Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. , 2005, Chest.

[13]  J. Rello,et al.  Pneumonia caused by oxacillin-resistant Staphylococcus aureus treated with glycopeptides* , 2005, Critical care medicine.

[14]  S. Kaplan,et al.  Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  Mian Cai,et al.  Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  D. Church,et al.  New Quadriplex PCR Assay for Detection of Methicillin and Mupirocin Resistance and Simultaneous Discrimination of Staphylococcus aureus from Coagulase-Negative Staphylococci , 2004, Journal of Clinical Microbiology.

[17]  J. Vilar,et al.  Radiology of bacterial pneumonia. , 2004, European journal of radiology.

[18]  R. Wunderink,et al.  Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin , 2004, Intensive Care Medicine.

[19]  R. Wunderink,et al.  Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. , 2003, Chest.

[20]  F. Vandenesch,et al.  Community-Acquired Methicillin-Resistant Staphylococcus aureus Carrying Panton-Valentine Leukocidin Genes: Worldwide Emergence , 2003, Emerging infectious diseases.

[21]  A. El‐Solh,et al.  Impact of invasive strategy on management of antimicrobial treatment failure in institutionalized older people with severe pneumonia. , 2002, American journal of respiratory and critical care medicine.

[22]  S. Fridkin.  Increasing prevalence of antimicrobial resistance in intensive care units , 2001, Critical care medicine.

[23]  M. Fine,et al.  Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. , 2001, American journal of respiratory and critical care medicine.

[24]  M. González,et al.  Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  R. Gaynes,et al.  Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. , 1999, Critical care medicine.

[26]  P. Flanagan.  Diagnosis of ventilator-associated pneumonia. , 1997, The Journal of hospital infection.

[27]  M. Fine,et al.  A prediction rule to identify low-risk patients with community-acquired pneumonia. , 1997, The New England journal of medicine.

[28]  J. Rello,et al.  Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes. , 1994, American journal of respiratory and critical care medicine.

[29]  R. Rodríguez-Roisín,et al.  Specificity of endotracheal aspiration, protected specimen brush, and bronchoalveolar lavage in mechanically ventilated patients. , 1993, The American review of respiratory disease.

[30]  S. Tyler,et al.  Detection of genes for enterotoxins, exfoliative toxins, and toxic shock syndrome toxin 1 in Staphylococcus aureus by the polymerase chain reaction , 1991, Journal of clinical microbiology.

[31]  M. Guiguet,et al.  Detection of nosocomial lung infection in ventilated patients. Use of a protected specimen brush and quantitative culture techniques in 147 patients. , 1988, The American review of respiratory disease.

[32]  W. Johanson,et al.  Incidence, site, and outcome of infections in patients with the adult respiratory distress syndrome. , 1986, The American review of respiratory disease.